Literature DB >> 12861374

Factor XIII subunit A as an intracellular transglutaminase.

R Adány1, H Bárdos.   

Abstract

Over the last 2 decades there has been increasing evidence that the role of factor XIII (FXIII) is not restricted to the area of hemostasis and that its subunit A functions as an intracellular enzyme in platelets and monocytes/macrophages. FXIII is already expressed during compartmentalisation of the precursors of megakaryocyte/platelet and monocyte/macrophage cell lines in the bone marrow. FXIII-A, produced by megakaryocytes, is packaged into budding platelets and is present in huge quantity in circulating ones. It seems very likely that it plays an important role in the cytoskeletal remodelling associated with the activation stages of platelets. FXIII-A can also be detected in blood monocytes and in all subsets of monocyte-derived macrophages throughout the body. FXIII-A is mainly localised in the cytoplasm, in association with cytoskeletal filaments, but at a relatively early stage of macrophage differentiation it also appears transiently in the nucleus. Cytoplasmic expression has a very close relationship with phagocytic activities. Further research is needed to understand the biological significance of its nuclear presentation.

Mesh:

Substances:

Year:  2003        PMID: 12861374     DOI: 10.1007/s00018-003-2178-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  31 in total

Review 1.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

2.  Extracellular matrix modifications at fertilization: regulation of dityrosine crosslinking by transamidation.

Authors:  Julian L Wong; Gary M Wessel
Journal:  Development       Date:  2009-04-29       Impact factor: 6.868

3.  Identification of a FXIIIA variant in human neuroblastoma cell lines.

Authors:  Martina lannaccone; Gaia Giuberti; Giulia De Vivo; Michele Caraglia; Vittorio Gentile
Journal:  Int J Biochem Mol Biol       Date:  2013-07-29

4.  Critical role of factor XIII in the initial stages of carbon tetrachloride-induced adult liver remodeling.

Authors:  Ikuko Tsujimoto; Kei Moriya; Keiko Sakai; Gerhard Dickneite; Takao Sakai
Journal:  Am J Pathol       Date:  2011-10-19       Impact factor: 4.307

5.  Reversible activation of cellular factor XIII by calcium.

Authors:  Gunhild Klarskov Kristiansen; Mette Dahl Andersen
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

6.  Molecular patterning of the embryonic cranial mesenchyme revealed by genome-wide transcriptional profiling.

Authors:  Krishnakali Dasgupta; Jong Uk Chung; Kesava Asam; Juhee Jeong
Journal:  Dev Biol       Date:  2019-07-24       Impact factor: 3.582

7.  Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Tetsuji Takabayashi; Atsushi Kato; Anju T Peters; Kathryn E Hulse; Lydia A Suh; Roderick Carter; James Norton; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Shigeharu Fujieda; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-03-28       Impact factor: 10.793

Review 8.  Hemostasis components in cerebral amyloid angiopathy and Alzheimer's disease.

Authors:  Nicole Ziliotto; Francesco Bernardi; Fabrizio Piazza
Journal:  Neurol Sci       Date:  2021-05-27       Impact factor: 3.307

9.  Role of FcRgamma and factor XIIIA in coated platelet formation.

Authors:  Shawn M Jobe; Lorie Leo; Joshua S Eastvold; Gerhard Dickneite; Timothy L Ratliff; Steven R Lentz; Jorge Di Paola
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

10.  Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release.

Authors:  Sybille Rex; Lea M Beaulieu; David H Perlman; Olga Vitseva; Price S Blair; Mark E McComb; Catherine E Costello; Jane E Freedman
Journal:  Thromb Haemost       Date:  2009-07       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.